Icrucumab
Product Specifications
CAS Number
1024603-92-6
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis
Purity
>95%
Bioactivity
Icrucumab (IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1.Icrucumab has antitumor activity.Icrucumab has been studied in metastatic colon cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
